DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
Loading...
  • Stocks
  • /
  • Materials
Updated 1m ago
000930 logo

COFCO Biotechnology Co., Ltd.SZSE:000930 Stock Report

Market Cap CN¥10.0b
Updated 1m ago
Share Price
n/a
1Y-8.8%
7D2.3%
1D4.6%
Portfolio Value
​
View

COFCO Biotechnology Co., Ltd.

SZSE:000930 Stock Report

Market Cap: CN¥10.0b

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

COFCO Biotechnology (000930) Stock Overview

Engages in the processing of agricultural products in China. More details

000930 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth3/6
Past Performance0/6
Financial Health4/6
Dividends1/6

Rewards

Earnings are forecast to grow 111.35% per year

Trading at good value compared to peers and industry

Risk Analysis

Dividend of 0.55% is not well covered by earnings or free cash flows


000930 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW431,284 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
431,284 investors already sharing narratives
CN¥
Current Price
CN¥5.4162.9% undervalued intrinsic discount
%/yr
Decrease
Increase
PastFuture-1b23b2016201920222025202620282031Revenue CN¥20.2bEarnings CN¥1.9b
Advanced
View all narratives

COFCO Biotechnology Co., Ltd. Competitors

Wankai New Materials

Symbol: SZSE:301216
Market cap: CN¥10.1b

Shandong Boyuan Pharmaceutical & Chemical

Symbol: SZSE:301617
Market cap: CN¥9.3b

Suzhou Kingswood Education Technology

Symbol: SZSE:300192
Market cap: CN¥8.5b

ValiantLtd

Symbol: SZSE:002643
Market cap: CN¥12.3b

Price History & Performance

Summary of share price highs, lows and changes for COFCO Biotechnology
Historical stock prices
Current Share PriceCN¥5.41
52 Week HighCN¥8.14
52 Week LowCN¥4.24
Beta0.21
1 Month Change14.62%
3 Month Change14.86%
1 Year Change-8.77%
3 Year Change-22.49%
5 Year Change-48.91%
Change since IPO-65.26%

Recent News & Updates

Recent updates

Analysis Article • Feb 24

COFCO Biotechnology Co., Ltd.'s (SZSE:000930) Prospects Need A Boost To Lift Shares

With a price-to-sales (or "P/S") ratio of 0.5x COFCO Biotechnology Co., Ltd. ( SZSE:000930 ) may be sending bullish...
Analysis Article • Jan 07

COFCO Biotechnology (SZSE:000930) Is Making Moderate Use Of Debt

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article • Oct 14

COFCO Biotechnology Co., Ltd. (SZSE:000930) Surges 39% Yet Its Low P/S Is No Reason For Excitement

COFCO Biotechnology Co., Ltd. ( SZSE:000930 ) shareholders would be excited to see that the share price has had a great...
Analysis Article • Sep 30

We Think COFCO Biotechnology (SZSE:000930) Has A Fair Chunk Of Debt

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article • Jul 17

COFCO Biotechnology Co., Ltd. (SZSE:000930) Looks Inexpensive But Perhaps Not Attractive Enough

With a price-to-sales (or "P/S") ratio of 0.5x COFCO Biotechnology Co., Ltd. ( SZSE:000930 ) may be sending bullish...
Analysis Article • Jun 03

COFCO Biotechnology (SZSE:000930) Is Carrying A Fair Bit Of Debt

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Analysis Article • Apr 17

Returns On Capital Signal Tricky Times Ahead For COFCO Biotechnology (SZSE:000930)

What trends should we look for it we want to identify stocks that can multiply in value over the long term? In a...
Analysis Article • Mar 07

COFCO Biotechnology Co., Ltd.'s (SZSE:000930) Price Is Right But Growth Is Lacking

COFCO Biotechnology Co., Ltd.'s ( SZSE:000930 ) price-to-sales (or "P/S") ratio of 0.6x might make it look like a buy...

Shareholder Returns

000930CN ChemicalsCN Market
7D2.3%2.3%1.7%
1Y-8.8%17.2%0.9%

Return vs Industry: 000930 underperformed the CN Chemicals industry which returned 17.2% over the past year.

Return vs Market: 000930 underperformed the CN Market which returned 0.9% over the past year.

Price Volatility

Is 000930's price volatile compared to industry and market?
000930 volatility
000930 Average Weekly Movement7.6%
Chemicals Industry Average Movement7.6%
Market Average Movement7.0%
10% most volatile stocks in CN Market11.8%
10% least volatile stocks in CN Market4.1%

Stable Share Price: 000930 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 000930's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19984,571Manyi Wangcofcotech.com

COFCO Biotechnology Co., Ltd., together with its subsidiaries, engages in the processing of agricultural products in China. The company offers ethanol disinfectants, pharmaceutical ethanol, edible alcohol, anhydrous ethanol, and denatured fuel ethanol; edible corn starch; and flavoring, glucose, malt, and high fructose syrup. It also provides food additives and others, such as corn crude oil, phytosterol red yeast rice tea polyphenol tablets, natural vitamin E soft capsules, phytosterols, and vitamin E; corn germ meal, sprayed corn husks, corn protein powder, and corn dried alcohol distillers; and polylactic acid products.

COFCO Biotechnology Co., Ltd. Fundamentals Summary

How do COFCO Biotechnology's earnings and revenue compare to its market cap?
000930 fundamental statistics
Market capCN¥10.04b
Earnings (TTM)-CN¥238.17m
Revenue (TTM)CN¥16.89b
0.6x
P/S Ratio
-42.2x
P/E Ratio

Is 000930 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
000930 income statement (TTM)
RevenueCN¥16.89b
Cost of RevenueCN¥16.25b
Gross ProfitCN¥642.30m
Other ExpensesCN¥880.47m
Earnings-CN¥238.17m

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

n/a

Earnings per share (EPS)-0.13
Gross Margin3.80%
Net Profit Margin-1.41%
Debt/Equity Ratio49.0%

How did 000930 perform over the long term?

See historical performance and comparison

Dividends

0.6%
Current Dividend Yield
-23%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/21 17:11
End of Day Share Price 2026/09/21 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

COFCO Biotechnology Co., Ltd. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Xia ShengCitic Securities Co., Ltd.
Wei LiuHaitong International Research Limited
Jiao ChenIndustrial Securities Co. Ltd.

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide